Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndrome

Neurology. 2003 Sep 23;61(6):873; author reply 873.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Autoimmune Diseases of the Nervous System / genetics
  • Autoimmune Diseases of the Nervous System / therapy*
  • Female
  • Gait Ataxia / etiology*
  • Gait Ataxia / therapy
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Polyneuropathies / etiology*
  • Polyneuropathies / therapy
  • Remission Induction
  • Sensation Disorders / etiology*
  • Sensation Disorders / therapy
  • Sjogren's Syndrome / complications
  • Sjogren's Syndrome / genetics
  • Sjogren's Syndrome / therapy*

Substances

  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents